IP Library Granted Patent US 8,853,309
Granted Patent B2
US 8,853,309 · App. 13/121,497 · Granted Oct 7, 2014

Curable composition and cured product thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,853,309
App. No.
13/121,497
Granted
Oct 7, 2014
Kind
B2
Abstract

The present invention aims to provide a curable composition without adverse effects on the environment, which exhibits excellent curability without containing a toxic organotin curing catalyst, and gives a cured product that does not have discoloration and cracks on the surface thereof even after being exposed to the atmosphere and ultraviolet light for a long time. The present invention also aims to provide the cured product. The curable composition comprises: (A) an organic polymer having a reactive silyl group; (B) a guanidine compound having a specific structure; and (C) a phosphorus compound that has an aryl group, has a phosphorus atom with an oxidation number of +5, and has a melting point of 23° C. or higher.

Claims (22)

1. A curable composition comprising:

(A) an organic polymer having a silyl group cross-linkable by siloxane bond formation and, as a main chain skeleton, a polyoxyalkylene polymer;

(B) a guanidine compound as a silanol condensation catalyst, represented by formula (1):

R 1 N═C(NR 1 2 ) 2   (1)

wherein each of the five R 1 s is independently at least one selected from the group consisting of a hydrogen atom, a hydroxy group, an amino group, a nitro group, a cyano group, a sulfonic acid group, and an organic group, provided that at least one of the five R 1 s is an aryl group; and

(C) a phosphorus compound that has an aryl group, has a phosphorus atom with an oxidation number of +5, and has a melting point of 23° C. or higher.

2. The curable composition according to claim 1 ,

wherein the phosphorus compound (C) is a phosphate ester compound.

3. The curable composition according to claim 1 ,

wherein the phosphorus compound (C) is a metal salt of a phosphate ester.

4. The curable composition according to claim 1 ,

wherein a blending amount of the phosphorus compound (C) is 2 to 20 parts by weight for each 100 parts by weight of the organic polymer (A).

5. The curable composition according to claim 1 ,

wherein the guanidine compound (B) is represented by formula (2):

wherein each of the four R 1 s is independently at least one selected from the group consisting of a hydrogen atom, a hydroxy group, an amino group, a nitro group, a cyano group, a sulfonic acid group, and an organic group; each of the a R 2 s is at least one selected from the group consisting of a hydrogen atom, a halogen atom, a hydroxy group, an amino group, a nitro group, a cyano group, a sulfonic acid group, and an organic group; and a is an integer of 1 to 5.

6. The curable composition according to claim 1 ,

wherein the guanidine compound (B) is at least one selected from the group consisting of 1-phenylguanidine, 1-(o-tolyl)guanidine, 1-phenylbiguanide, and 1-(o-tolyl) biguanide.

7. The curable composition according to claim 1 ,

wherein the polyoxyalkylene polymer is a polyoxypropylene polymer.

8. A sealant, comprising the curable composition according to claim 1 .

9. An adhesive, comprising the curable composition according to claim 1 .

10. A cured product, which is produced from the curable composition according to claim 1 .

Assignments (2)
CHANGE OF ADDRESS Recorded Sep 12, 2013
From: KANEKA CORPORATION
To: KANEKA CORPORATION
Reel/Frame 031207/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2011
From: YANO, AYAKO; NORO, NORIKO
To: KANEKA CORPORATION
Reel/Frame 026399/0883 →